Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Mylan Inc    MYL   US6285301072

MYLAN INC (MYL)

71
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/23/2015 02/24/2015 02/25/2015 02/26/2015 02/27/2015 Date
57.65(c) 57.215(c) 56.5(c) 57.245(c) 57.39 Last
1 988 311 1 952 482 3 365 278 2 029 526 4 597 537 Volume
-0.38% -0.75% -1.25% +1.32% +0.25% Change
More quotes
Company
Mylan, Inc. is a generic and specialty pharmaceuticals company, through its subsidiaries, which develops, manufactures, markets and distributes pharmaceuticals.The company operates its business through two segments: Generics & Specialty.The Generics segment primarily develops, manufactures, sells... 
Sector
Pharmaceuticals
Calendar
03/02Earnings Release
More about the company
Surperformance© ratings of Mylan Inc
Trading Rating : Investor Rating :
More Ratings
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | MYL | US6285301072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 7 723 M
EBIT 2014 1 983 M
Net income 2014 1 189 M
Debt 2014 7 679 M
Yield 2014 -
Sales 2015 9 819 M
EBIT 2015 2 768 M
Net income 2015 1 886 M
Debt 2015 6 580 M
Yield 2015 -
PER 2014 20,05
PER 2015 15,42
EV / Sales 2014 3,77x
EV / Sales 2015 2,85x
Capitalization 21 425 M
More Financials
Latest news on MYLAN INC
02:05p MYLAN : Entry into a Material Definitive Agreement, Completion of Acquisition or..
12:54p MYLAN : Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi® an..
02/26 MYLAN : Trademark Application for "MAKE IT MYLAN" Filed by Mylan
02/23 MYLAN : Specialty to Present Findings from EpiPen4Schools® Program Survey
02/23 MYLAN : Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi® an..
02/22DJValeant Pharmaceuticals to Buy Salix for About $10 Billion -- 2nd Update
02/22DJValeant Pharmaceuticals to Buy Salix for About $10 Billion -- Update
02/19 Mylan Confirms First-to-File Patent Challenge Relating to NEXAVAR®
More news
Sector news Pharmaceuticals - NEC
04:06p ZOETIS : Declares Second Quarter 2015 Dividend
01:35p BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts Biologics Licen..
12:31p ABBOTT LABORATORIES : Mylan Completes Acquisition Of Abbott's Non-U.S. Developed..
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF